CompletedPhase 2NCT01801449
Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)
Studying Autoinflammatory syndrome with skin involvement
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Principal Investigator
- Gina A Montealegre, M.D.National Institute of Allergy and Infectious Diseases (NIAID)
- Intervention
- Rilonacept(drug)
- Enrollment
- 6 enrolled
- Eligibility
- All sexes
- Timeline
- 2013 – 2016
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Collaborators
National Institutes of Health Clinical Center (CC)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01801449 on ClinicalTrials.gov